Short peptides like GRP, bombesin and their analogues have been linked to radioactive isotopes as a means to label GRPR in prostate cancer and potentially to treat prostate cancer10, 11, 12, 13, 43, 44, 45, 46, 47, 48. Here, GRP is linked to prostate carcinoma.